About Mymee
Mymee is a digital therapeutics company that has developed the first clinically validated platform for identifying and managing autoimmune disease triggers through personalized environmental analysis. The company's proprietary method helps patients with rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, long COVID, and other autoimmune conditions discover hidden triggers in their exposome—the environmental factors that influence disease flares. The platform combines a custom mobile app, proprietary data analytics, and weekly one-on-one sessions with specialized health coaches to correlate symptoms with environmental triggers. Clinical studies have demonstrated that Mymee's approach achieves a mean reduction of over 40% in moderate to high-frequency symptoms, with more than 70% of patients reversing their health-related quality of life severity from moderate-to-severe to mild-to-normal as measured by PROMIS. The solution empowers patients to gain control over their autoimmune conditions in an average of 17 weeks through personalized trials that identify unique sensitivities to diet, lifestyle, and environmental factors. Mymee's coach-led platform also provides medication tapering support based on genetics, personal preferences, and health needs, working in accordance with physician and pharmacist-recommended drug regimens. The company serves patients who are non-responders to standard therapies and those seeking to reduce reliance on medications through evidence-based lifestyle interventions.
Clinical Focus
Medical conditions and clinical areas addressed by Mymee.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired Breakthrough Health, a leading digital health platform for multiple sclerosis
Awards & Recognition
Industry recognition from healthcare leaders including former Head of Population Health at Oscar Health and VP External Innovation at Johnson & Johnson
Key Partnerships
Social & Media
Latest Updates
Mymee’s Personalized Trial & Care Platform Helps Autoimmune Disease Patients Reverse Flares, New Research Shows
3y ago
Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis
3y ago
Video: An Evening With Meghan O’Rourke
4y ago
Recognizing Multiple Sclerosis: An MS Symptoms Checklist
4y ago
What are the Symptoms of Celiac Disease?
4y ago
Company Details
- Headquarters
- New York, NY, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.